INNOPREP
LIVE

Serial Number

79248801

Owner

BIOFARMA

Attorney

Maury M. Tepper, III

Filing Date

Aug 3, 2018

Add to watchlist:

No watchlists yet
View on USPTO

INNOPREP Trademark

Serial Number: 79248801 • Registration: 5876650

INNOPREP is a trademark filed by BIOFARMA on August 3, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

BIOFARMA (296 trademarks)

50, rue Carnot
Suresnes cedex 92284 , FR

Entity Type: 03

Trademark Details

Filing Date

August 3, 2018

Registration Date

October 8, 2019

Published for Opposition

July 23, 2019

Cancellation Date

April 24, 2026

Goods & Services

Pharmaceutical, medical and veterinary preparations all for the prevention and treatment of cardiovascular, autoimmune and inflammatory, neurodegenerative, respiratory, and metabolic disorders and diseases; pharmaceutical, medical and veterinary preparations all for the prevention and treatment of diabetes, osteoporosis, and cancer; sanitary sterilizing preparations for medical purposes; sanitary preparations for medical use; dietetic sugar for medical use; dietetic foods adapted for medical purposes; dietetic beverages adapted for veterinary use; dietetic infusions for medical use; dietetic foods, namely crackers for medical use; dietetic foods for treating gastrointestinal disorders and diabetes for medical and veterinary use; food for babies; food supplements for humans and animals; medical plasters; medical dressings; wound dressings; burn dressings; gauze for dressings; self-adhesive dressings; material for dental fillings and dental impressions; disinfectants; natural remedy preparations for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances, and sleep disorders; probiotic supplements; probiotic preparations for medical use; dietary fiber to aid digestion; dietary fiber for treating constipation; dietary fiber for use as an ingredient in the manufacture of dietary supplements; stem cells for medical or veterinary use; pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; medicaments to help assist with the regeneration of ligament and tendon fibers; enzymes for medical and veterinary use; phototherapy preparations for medical use

Chemicals for use in industry and science; photographic chemicals; chemical compositions for developing photographs; chemicals for use in agriculture, horticulture and forestry, except fungicides, herbicides, insecticides and parasiticides; industrial chemicals for the treatment of liquids; chemicals for the treatment of industrial water and wastewater; unprocessed artificial resins; soil fertilizers; fire-extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning agents for use in the manufacture of leather, namely, oils for tanning leather; enzymes for use in the tanning of leather; adhesives for use in industry; chemical preparations for use in the manufacture of pharmaceuticals; chemical preparations for use in the manufacture of cosmetics; chromatography chemicals; chromatography chemicals for the separation of liquids

Scientific and technological services, namely, research and design in the field of integrated system architecture that allows for the rapid development of highly interactive and customizable learning applications; scientific and technological services, namely, research and design in the field of computer networking hardware, computer datacenter architecture; technology research in the field of medical instruments; design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for scientific and technological applications; scientific research and development; DNA analysis services for scientific research purposes; scientific research for medical purposes in the field of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; scientific research in the field of genetics and genetic engineering; industrial research in the field of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders and scientific analysis related thereto; design and development of computer hardware and software; research, development and design of computer software for use in medical diagnosis and disease analysis; scientific research in the nature of conducting clinical trials for others; conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; scientific laboratory services; scientific study and research projects in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; engineering; energy auditing; scientific and technological research in the field of chromatography; research in the field of chemistry ; chemistry consultation; product testing; pharmaceutical product evaluation and testing; product quality evaluation; laboratory research and analysis in the field of chromatography; consulting services in the field of design and development of engineering processes for the transformation and purification of liquids, molecules and raw materials for others; consulting services in the field of cloud computing; providing virtual computer systems and virtual computer environments through cloud computing; rental of computer software; updating of software; programming for computers; research and development of new products for others; electronic data storage; providing a web hosting platform for scientific and medical research in the fields of the prevention and treatment of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; web site hosting services; providing temporary use of on-line non-downloadable software for use in database management accessible via an Internet website; designing Internet websites for others in the field of shared document collaboration; engineering services relating to robotics; development of software for patients; chemical engineering; materials testing

Filing History

CANCELLED SECTION 71
Apr 24, 2026 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 8, 2024 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 21, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 3, 2020 FICS
FINAL DISPOSITION PROCESSED
Feb 3, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 8, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 8, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 23, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jul 23, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 3, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 19, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 19, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 19, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 19, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 19, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 7, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 7, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 7, 2019 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 23, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 23, 2019 REAP
REFUSAL PROCESSED BY IB
Mar 8, 2019 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 20, 2019 RFCS
REFUSAL PROCESSED BY MPU
Feb 19, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 23, 2019 RFCR
NON-FINAL ACTION WRITTEN
Jan 22, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Jan 22, 2019 MAFR
ASSIGNED TO EXAMINER
Jan 17, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 17, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jan 14, 2019 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 3, 2019 REPR